2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9851):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-141913S
    3-Chlorotyrosine-13C9,15N hydrochloride
    3-Chlorotyrosine-13C9,15N (hydrochloride) is the 13C and 15N labeled 3-Chlorotyrosine.
    3-Chlorotyrosine-<sup>13</sup>C<sub>9</sub>,<sup>15</sup>N hydrochloride
  • HY-120986S
    (S)-Bromoenol lactone-d7
    (S)-Bromoenol lactone-d7 is the deuterium labeled (S)-Bromoenol lactone.
    (S)-Bromoenol lactone-d<sub>7</sub>
  • HY-146767S
    (3β,5α,6β)-3,5,6-Trihydroxycholan-24-oic acid-d4
    (3β,5α,6β)-3,5,6-Trihydroxycholan-24-oic acid-d4 is deuterium labeled (3β,5α,6β)-3,5,6-Trihydroxycholan-24-oic acid.
    (3β,5α,6β)-3,5,6-Trihydroxycholan-24-oic acid-d<sub>4</sub>
  • HY-109101AS1
    Risdiplam-hydroxylate-d3
    Risdiplam-hydroxylate-d3 is a Risdiplam-hydroxylate tritium substitute. Risdiplam (RG7916) is an orally administered, centrally and peripherally distributed SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels.
    Risdiplam-hydroxylate-d<sub>3</sub>
  • HY-B1589AS
    Carbinoxamine-d6 maleate
    Carbinoxamine-d6 (maleate) is the deuterium labeled Carbinoxamine maleate salt. Carbinoxamine maleate salt is a histamine H1 receptor antagonist.
    Carbinoxamine-d<sub>6</sub> maleate
  • HY-17367S4
    Atazanavir-d6
    		99.28%
    Atazanavir-d6 is deuterium labeled Atazanavir. Atazanavir (BMS-232632), a highly selective HIV-1 protease inhibitor, is the first protease inhibitor approved for once-daily administration. Atazanavir (BMS-232632) is a substrate and inhibitor of CYP3A4, and an inhibitor and inducer of P-glycoprotein (P-gp). Atazanavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 3.49 μM.
    Atazanavir-d<sub>6</sub>
  • HY-N2044S
    Methyl 3,4,5-trimethoxybenzoate-d9
    Methyl 3,4,5-trimethoxybenzoate-d9 is the deuterium labeled Methyl 3,4,5-trimethoxybenzoate. Methyl 3,4,5-trimethoxybenzoate can be synthesized from Gallic acid. Methyl 3,4,5-trimethoxybenzoate is mainly used in the production of Trimethoprim (TMP), Sulfa synergistic intermediates, and many other agents.
    Methyl 3,4,5-trimethoxybenzoate-d<sub>9</sub>
  • HY-B0703S
    Eslicarbazepine acetate-d4
    Eslicarbazepine acetate-d4 is deuterated labeled Eslicarbazepine acetate (HY-B0703). Eslicarbazepine acetate (BIA 2-093), an antiepileptic agent, is a dual a dual Inhibitor of β-Secretase and voltage-gated sodium channel.
    Eslicarbazepine acetate-d4
  • HY-166939S
    3,4,5,6-Tetrabromo[1,1′-biphenyl]-2,2′-diol-13C12
    3,4,5,6-Tetrabromo[1,1′-biphenyl]-2,2′-diol-13C12 is 13C labeled 3,4,5,6-Tetrabromo[1,1′-biphenyl]-2,2′-diol.
    3,4,5,6-Tetrabromo[1,1′-biphenyl]-2,2′-diol-<sup>13</sup>C<sub>12</sub>
  • HY-B0426AS1
    (Z)-Olopatadine-d3 hydrochloride
    (Z)-Olopatadine-d3 (hydrochloride) is deuterium labeled Olopatadine (hydrochloride).
    (Z)-Olopatadine-d<sub>3</sub> hydrochloride
  • HY-101952S1
    Prostaglandin E2-d9
    Prostaglandin E2-d9 is the deuterium labeled Prostaglandin E2. Prostaglandin E2 (PGE2) is a hormone-like substance that participate in a wide range of body functions such as the contraction and relaxation of smooth muscle, the dilation and constriction of blood vessels, control of blood pressure, and modulation of inflammation.
    Prostaglandin E2-d<sub>9</sub>
  • HY-W009455S
    9-Bromoanthracene-d9
    9-Bromoanthracene-d9 is the deuterium labeled 9-Bromoanthracene (HY-W009455).
    9-Bromoanthracene-d<sub>9</sub>
  • HY-75054S
    Abiraterone acetate-d4
    Abiraterone acetate-d4 is the deuterium labeled Abiraterone acetate. Abiraterone acetate (CB7630) is an oral, potent, selective, and irreversible inhibitor of CYP17A1 with antiandrogen activity. Abiraterone acetate is a proagent form of Abiraterone (CB7598).
    Abiraterone acetate-d<sub>4</sub>
  • HY-W707693
    Scyllo-Inositol-d6
    Scyllo-Inositol-d6 is the deuterium labeled Scyllo-Inositol (HY-W010041). Scyllo-Inositol is an inhibitor that targets the aggregation of misfolded proteins (such as α-synuclein and Amyloid-β), is orally effective, and can cross the blood-brain barrier. Scyllo-Inositol can selectively bind to and stabilize non-toxic oligomers, preventing them from converting into toxic fibers, exerting protein homeostasis regulation and neuroprotective activity. Scyllo-Inositol binds to the hydrophobic region of pathogenic proteins, inhibits protein aggregation, and promotes lysosome- and proteasome-mediated degradation pathways, thereby reducing neurotoxicity. Scyllo-Inositol can be used in the study of neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and Huntington's disease.
    Scyllo-Inositol-d<sub>6</sub>
  • HY-W757658
    O-Desethyl resiquimod-O-acetate-d6
    O-Desethyl resiquimod-O-acetate-d6 is the deuterium labeled O-Desethyl resiquimod-O-acetate.
    O-Desethyl resiquimod-O-acetate-d<sub>6</sub>
  • HY-146967S
    4-(3,6-Dimethylhept-3-yl)phenol-13C6
    4-(3,6-Dimethylhept-3-yl)phenol-13C6 is the 13C6 labeled 4-(3,6-Dimethylhept-3-yl)phenol.
    4-(3,6-Dimethylhept-3-yl)phenol-<sup>13</sup>C<sub>6</sub>
  • HY-W766078
    1-beta-D-Arabinofuranosyluracil-13C,15N2
    1-beta-D-Arabinofuranosyluracil-13C,15N2 (1-b-D-Arabinofuranosyluracil-13C,15N2; Uracil 1-β-D-arabinofuranoside-13C,15N2) is the 13C- and 15N-labeled labeled 1-beta-D-Arabinofuranosyluracil (HY-N6652). 1-beta-D-Arabinofuranosyluracil (Uracil 1-β-D-arabinofuranoside) isolated from the Caribbean sponge Tectitethya crypta, is a methoxyadenosine derivative. 1-beta-D-Arabinofuranosyluracil has demonstrated a diverse bioactivity profile including anti-inflammatory activity, analgesic and vasodilation properties. 1-beta-D-Arabinofuranosyluracil reduces a proliferation of mouse lymphoma cells.
    1-beta-D-Arabinofuranosyluracil-<sup>13</sup>C,<sup>15</sup>N<sub>2</sub>
  • HY-W778393
    cis-Tranexamic acid-13C2,15N
    cis-Tranexamic acid-13C2,15N is 13C and 15N labeled cis-Tranexamic acid.
    cis-Tranexamic acid-<sup>13</sup>C<sub>2</sub>,<sup>15</sup>N
  • HY-B0602S
    (R)-(-)-O-Desmethyl Venlafaxine-d6
    (R)-(-)-O-Desmethyl Venlafaxine-d6 is the deuterium labeled (R)-(-)-O-Desmethyl Venlafaxine. O-Desmethyl Venlafaxine is an active metabolite of Venlafaxine. Venlafaxine (HY-B0196) is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class.
    (R)-(-)-O-Desmethyl Venlafaxine-d<sub>6</sub>
  • HY-150844S
    Ethylbenzene-2,3,4,5,6-d5
    Ethylbenzene-2,3,4,5,6-d5 is the deuterium labeled Ethylbenzene.
    Ethylbenzene-2,3,4,5,6-d<sub>5</sub>